ABVC 8-K 2026-08-12

ABVC BIOPHARMA, INC. (ABVC) 8-K dated 2026-08-12 — accession 0001213900-26-088165. This URL is the filing, not the ABVC hub.

ABVC BIOPHARMA, INC. (ABVC) is a biotechnology company listed on NASDAQ.

ABVC BIOPHARMA, INC. filed a 8-K on 2026-08-12. Accession 0001213900-26-088165.

Cached items: 8.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ABVC revenue for 2025-09-30 was $796.0K. Net income was -$1.3M. ABVC currently screens at market cap $35.9M.

Not investment advice. The ABVC SEC hub lists recent forms. The stock page is the research view.